Proposed Hydroquinone Ban Criticized In Literature Review
This article was originally published in The Rose Sheet
Executive Summary
Disrupting the availability of hydroquinone skin-lightening products would represent an "overreaction" by FDA, according to a literature review published in the November issue of the Journal of the American Academy of Dermatology